Tissue Therapies Ltd. reported consolidated earnings results for the half year ended December 31, 2015. For the period, the company reported income from continuing operations of AUD 208,720 compared to AUD 268,321 a year ago. Loss before income tax expense was AUD 9,580,808 compared to AUD 5,024,261 a year ago.

Loss attributable to members of the company was AUD 9,581,073 or 3.16 cents per basic and diluted share compared to AUD 5,030,939 or 1.91 cents per basic and diluted share a year ago. Net cash used in operating activities was AUD 2,826,484 compared to AUD 4,230,449 a year ago.